|
|
| (113 intermediate revisions by 5 users not shown) |
| Line 1: |
Line 1: |
| | <span style="display:none">forresearchers</span> |
| | <span style="display:none">forpatients</span> |
| | <span style="display:none">forproviders</span> |
| | <span style="display:none">forpolicymakers</span> |
| | <span style="display:none">thenetherlandscountry</span> |
| | [https://wiki.beaconcancer.org/index.php?title=Cancer_Centers Go back to Cancer Centers list.] |
| | |
| == Cancer Centers == | | == Cancer Centers == |
| | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
|
| |
|
| == Healthcare System ==
| | [[hasCancerCenter::Netherlands Cancer Institute - Antoni van Leeuwenhoek]] |
| | |
| The Netherlands employs a three-tiered system of healthcare funding: 1) a social insurance system for curative care operated by competing private insurers; 2) a single-payer social insurance for long-term care; 3) a tax-funded social care system implemented by municipalities. This structure ensures broad universal healthcare coverage for all residents.
| |
|
| |
|
| The Ministry of Health, Welfare, and Sport oversees the system. The Dutch Healthcare Authority regulates and sets healthcare prices. Health Insurance Board manages health insurance funds. Local authorities play a key role in the social care system, aiding in public health and social support. | | [[hasCancerCenter::The Maastricht UMC+ Comprehensive Cancer Center]] |
|
| |
|
| Residents have broad access to healthcare benefits, including GP services, medical specialists, hospital care, mental healthcare, maternity care, pharmaceuticals, medical aids, and some allied care services. The social care system supports housekeeping, help with daily activities, and sheltered living, and long-term care insurance covers intensive, continuous care.
| | [[hasCancerCenter::University Medical Center Groningen Comprehensive Cancer Center]] |
|
| |
|
| All residents and workers in the Netherlands must have standard health insurance. Insurance companies must accept every resident in their coverage area. The Netherlands operates a strict gatekeeper system; a referral from a GP is necessary for hospital and specialist care. Premiums are income-dependent, with allowances for low-income groups.
| | [[hasCancerCenter::Erasmus MC Kanker Instituut]] |
|
| |
|
| The Netherlands boasts a comprehensive digital healthcare infrastructure. EHR systems are widely used among GPs, pharmacists, hospitals, and other healthcare providers. The national exchange point (Landelijk Schakelpunt or LSP) allows secure exchange of medical data among healthcare providers. Specific registries exist for certain diseases and interventions, ensuring high-quality data for monitoring, research, and quality improvement.
| | [[hasCancerCenter::Radboudumc Centre for Oncology]] |
|
| |
|
| == Administrative or Claims Data ==
| | [[hasCancerCenter::Rijnstate]] |
| <!-- | | </div> |
| === Database: ===
| |
|
| |
|
| '''Primary purpose:''' Make information about the Neatherland's healthcare available.
| | == [[hasHealthcareSystem::Healthcare_System_(The_Netherlands)|Healthcare System]] == |
| | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
|
| |
|
| '''Sponsor, manager or home institution''': DBC information system (DIS).
| | </div> |
|
| |
|
| '''Type of information''':
| | == Administrative or Claims Data == |
| | | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
| '''Source of information''':
| |
| | |
| '''Data level''':
| |
| | |
| '''Number of Records:'''
| |
| | |
| '''Date range''':
| |
| | |
| '''Cancer Areas of Interest:'''
| |
| | |
| '''Data access''':
| |
| | |
| '''Information/contact for data request''': [ Contact information].
| |
| -->
| |
| === Database: National Basic Register of Hospital Care (LBZ) ===
| |
| [https://www.dhd.nl/assets/uploads/Gebruikershandleiding-Landelijke-Basisregistratie-Ziekenhuiszorg-LBZ.pdf] [https://www.dhd.nl/producten-diensten/registratie-data/ontdek-de-mogelijkheden-van-de-lbz]
| |
| | |
| '''Primary purpose:''' Reunite administrative, financial, and medical data from hospitals all around the Netherlands, facilitating policymaking and research processes.
| |
| | |
| '''Sponsor, manager or home institution''': Dutch Hospital Data Foundation (DHD).
| |
| | |
| '''Type of information''': [[Data dictionary - National Basic Register of Hospital Care (LBZ)]].
| |
| | |
| There are other resources available:
| |
| * The Oncological Care Monitor: it is a partnership between the Netherlands Cancer Registry (NKR) and the National Basic Register of Hospital Care (LBZ). It aims to increase the availability of information about the treatments used in each type of cancer diagnosis and the number of diagnoses for each region by combining data from the two databases. Also, there is information about palliative care and care in the last phase of life of cancer patients who died in hospital. These informations are very useful for hospitals to compare their methods and numbers with other hospitals in different regions or with the national average [https://www.dhd.nl/producten-diensten/pati%C3%ABntenzorg-kwaliteit/inzicht-in-oncologische-zorg].
| |
| | |
| | |
| '''Source of information''': Hospital's reports.
| |
| | |
| '''Data level''': Patient-level.
| |
| | |
| '''Number of Records:''' Unknown.
| |
| | |
| '''Date range''': Data referring from 1991 to 2013 are from the Dutch Medical Registration (LMR) and are also available in the registry. The National Basic Register of Hospital Care (LBZ) replaced this entity and offers standardized data from 2014 on.
| |
| | |
| '''Cancer Areas of Interest:''' Unknown.
| |
| | |
| '''Data access''': Not publicly available. Instructions to request data for restricted content about patient-level [https://www.dhd.nl/producten-diensten/registratie-data/aanvraag-van-ziekenhuisdata]. Instructions to request data for restricted content about the Oncological Care Monitor [https://www.dhd.nl/over-ons/toegang-tot-producten]. It is also possible to register for a demo of the Oncological Care Monitor [https://www.dhd.nl/bijeenkomsten/demo-monitor-oncologische-zorg].
| |
| | |
| '''Information/contact for data request''': Contact information [https://www.dhd.nl/contact].
| |
| | |
| == [[Registries]] == | |
| | |
| === Database: Netherlands Cancer Registry (NKR) === | |
| [https://iknl.nl/nkr/over-nkr] [https://iknl.nl/nkr/uitleg-nkr-cijfers]
| |
| | |
| '''Primary purpose:''' Registry and monitor cancer statistics around Netherlands.
| |
| | |
| '''Sponsor, manager or home institution''': Comprehensive Cancer Center of the Netherlands (IKNL).
| |
| | |
| '''Available type of information''':
| |
| *Incidence: Count, crude rate per 100,000 persons per year, European Standardized Rate (ESR) per 100,000 persons per year, World Standardized Rate (WSR), Revised European Standardized Rate (RESR) by type of cancer, gender, age, region, and year.
| |
| *Prevalence: 5 year, 10 year, and 20 year prevalence by type of cancer, gender, age, region, and year.
| |
| *Mortality: Count, crude rate per 100,000 persons per year, European Standardized Rate (ESR) per 100,000 persons per year, World Standardized Rate (WSR), Revised European Standardized Rate (RESR) by type of cancer, gender, age, and year.
| |
| *Survival: relative survival by type of cancer, Period from diagnosis (1 year and 10 years), age at time of diagnosis, stage at time of diagnosis (TNM), and gender.
| |
| | |
| | |
| Also, there is a cancer atlas that informs of the incidence of cancer in each region of the Netherlands in the period of 2011–2020 and compares it to the Dutch average. This information can be selected by type of cancer, region, and gender.
| |
| | |
| '''Type of information''': The type of information available to each type of cancer at patient level can be seen in [https://iknl.nl/nkr/registratie/itemsets this] website.
| |
| | |
| '''Source of information''': Hospitals' reports.
| |
| | |
| '''Data level''': Regional level (open access) and Patient level (restricted access).
| |
| | |
| '''Number of Records:''' Contains information about all new cases of malignant neoplasms and some benign neoplasms (tumors of the central nervous system, borderline tumors of the ovary, and AL amyloidosis) in Netherlands.
| |
| | |
| '''Date range''': Varies according to the diagnosis and the type of information. It can be checked in [https://iknl.nl/nkr/registratie/itemsets this] website.
| |
| | |
| '''Cancer Areas of Interest:''' Regional data includes all invasive cancers except basal cell carcinoma of the skin.
| |
| | |
| '''Data access''': Regional level data is available [https://iknl.nl/nkr-cijfers here]. Access to patient level data can be requested by following the steps described [https://iknl.nl/nkr/cijfers-op-maat/gegevensaanvraag here]. The cancer atlas can be accessed [https://kankeratlas.iknl.nl/ here].
| |
| | |
| '''Information/contact for data request''': [https://iknl.nl/over-iknl/contact-adres Contact information].
| |
| | |
| === Database: Mortality by Cause of Death ===
| |
| [https://www.cbs.nl/nl-nl/onze-diensten/methoden/onderzoeksomschrijvingen/korte-onderzoeksbeschrijvingen/doodsoorzakenstatistiek]
| |
| | |
| '''Primary purpose:''' Publish data concerning the number of deaths in the territory.
| |
| | |
| '''Sponsor, manager or home institution''': Centraal Bureau voor de Statistiek.
| |
| | |
| '''Available type of information''': Number of deaths in the population of the Netherlands by main underlying cause of death (extensive list of 'three digit codes'), by age, gender, and year.
| |
| | |
| Deceased; leading causes of death (short list) by region, age, gender, and year.
| |
| | |
| '''Source of information''': Declaration of the cause of death and Basic personal registration (BRP) are sent from regional hospitals to the statistical organization.
| |
| | |
| '''Data level''': National level, Regional level (open access) and Patient level (restricted access).
| |
| | |
| '''Number of Records:''' Unknown.
| |
| | |
| '''Date range''': 1996 onwards (national and regional level) and 1995 onwards (patient level).
| |
| | |
| '''Cancer Areas of Interest:''' Total neoplasms (C00-D48); Total malignant neoplasms (C00-C97); Malignant neoplasms of lip, oral cavity and pharynx (C00-C14); Malignant neoplasms of oesophagus (C15); Malignant neoplasms of stomach (C16); Malignant neoplasms of colon (C18); Malignant neoplasms of rectum, rectosigmoid and anus (C19-C21); Malignants neoplasms of liver and intrahepatic bile ducts (C22.0 - C22.8); Malignant neoplasms of galbladder and bile ducts (C23-C24); Malignant neoplasms of pancreas (C25); Malignant neoplasms of larynx (C32); Malignant neoplasms of trachea, bronchus and lung, Trachea (windpipe) including branchings (C33-C34); Melanoma skin (C43); Malignant neoplasms of breast (C50); Malignant neoplasms of cervix uteri (C53); Malignant neoplasms of corpus uteri and uterus unspecified (C54-C55); Malignant neoplasms of ovary (C56); Malignant neoplasms of prostate (C61); Malignant neoplasms of kidney, except renal pelvis (C64); Malignant neoplasms of bladder (C67); Malignant neoplasms of lymphoid, heamatopoietic and related tissue (C81-C96); Other malignant neoplasms (C17, C22.9, C26-C31, C35-C41, C44-C49, C51-C52, C57-C60, C62-C63, C65-C66, C68-C80, C97); Other neoplasms (D00-D48). [https://www.cbs.nl/en-gb/figures/detail/7052eng]
| |
| | |
| '''Data access''': National level data can be accessed [https://opendata.cbs.nl/statline/portal.html?_la=en&_catalog=CBS&tableId=7233ENG&_theme=1133 here]. Regional level information can be accessed [https://opendata.cbs.nl/#/CBS/nl/dataset/80202ned/table?ts=1681159800171 here]. The required proccess to access patient level data can be checked [https://www.cbs.nl/nl-nl/onze-diensten/maatwerk-en-microdata/microdata-zelf-onderzoek-doen here].
| |
| | |
| '''Information/contact for data request''': [https://www.cbs.nl/nl-nl/onze-diensten/maatwerk-en-microdata/microdata-zelf-onderzoek-doen/contact Contact information].
| |
| | |
| === Database: Registry of histo and cytopathology ===
| |
| [https://www.palga.nl/gegevensaanvragen/excerpten.html]
| |
| | |
| '''Primary purpose:''' Provides organized pathology data to enhance the quality of diagnosis, treatment, and patient safety. Also facilitates scientific study.
| |
| | |
| '''Sponsor, manager or home institution''': the Pathological Anatomical National Automated Archive (PALGA).
| |
| | |
| '''Available type of information''': Number of diagnostics by type of disease (includes neoplasms), gender, year, age, and type of examination (cytology or histology).
| |
| | |
| To facilitate the search process for cancer terms, the main thesaurus codes used are listed in [https://www.palga.nl/assets/uploads/Gegevensaanvragen/Zoekvragen/deel%20E%20retrivaltermennieuw1B_10-2020.pdf this] document.
| |
| | |
| '''Type of information''': Report identification (laboratory number, year, type of study, pa number, and date of receipt of study material at the laboratory);
| |
| | |
| Patient data (pseudonymized patient identification, gender, and age);
| |
| | |
| Conclusion (conclusion in pathology report: free text or automatically generated from protocolized reporting module); diagnosis lines (one or more lines, consisting of diagnostic terms from thethesaurus, prepared according to fixed structure);
| |
|
| |
|
| Additional report data [kopacb code (diagnosis coding in cervical cytology), fields from standardized reporting module (e.G. Number of lymph nodes for colon carcinoma, grading in mammary carcinoma, etc.), clinical data, microscopy, macroscopy and epicrise].
| | === [[hasDatabase::Database:_National_Basic_Register_of_Hospital_Care_(LBZ)_(The_Netherlands)|Database: National Basic Register of Hospital Care (LBZ)]] === |
|
| |
|
| It is possible to integrate data from the Netherlands Cancer Registry (NKR) and this pathology registry. This adjustment makes the investigation much richer in information since it permits the researcher to have more information on each case. It is useful to obtain pathology history, information about sections or tissues, follow-up, and additional information about tumors from the NKR. This type of linkage is explained better [https://www.palga.nl/en/gegevensaanvragen-engels/koppelingen-engels.html here].
| | </div> |
|
| |
|
| '''Source of information''': Daily or weekly pathology reports from laboratories all around the Netherlands.
| | == Registries == |
| | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
|
| |
|
| '''Data level''': National-level (open access) and patient-level (restricted access).
| | === [[hasDatabase::Database:_Netherlands_Cancer_Registry_(NKR)_(The_Netherlands)|Database: Netherlands Cancer Registry (NKR)]] === |
|
| |
|
| '''Number of Records:''' Since 2017, when there were more than 72 million pathology results stored, the number of registries increases by approximately 2 million each year.
| | === [[hasDatabase::Database:_Mortality_by_Cause_of_Death_(The_Netherlands)|Database: Mortality by Cause of Death]] === |
|
| |
|
| '''Date range''': 1971 onwards. The registry has had nationwide information since 1991.
| | === [[hasDatabase::Database:_Registry_of_Histo_and_Cytopathology_(The_Netherlands)|Database: Registry of Histo and Cytopathology]] === |
|
| |
|
| '''Cancer Areas of Interest:''' All types of cancer. [https://www.palga.nl/assets/uploads/Gegevensaanvragen/Zoekvragen/deel%20E%20retrivaltermennieuw1B_10-2020.pdf]
| | === [[hasDatabase::Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)|Database: Dutch Institute for Clinical Auditing Databases (DICA)]] === |
|
| |
|
| '''Data access''': National-level data is available [https://www.palgaopenbaredatabank.nl/menu/main/home here] and there is some information and instructions about the use of this database [https://www.palga.nl/en/public-database.html here]. Access to patient-level information can be requested following the instructions presented [https://www.palga.nl/gegevensaanvragen/overzichtspagina-gegevensaanvragen.html here].
| | </div> |
|
| |
|
| '''Information/contact for data request''': [https://www.palga.nl/gegevensaanvragen/adviseurs.html Contact information].
| | == Databases for Clinical Trials, Surveys and Biobanks == |
| <!-- | | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
| === Database: === | | === [[hasDatabase::Survey:_National_Population_Surveys:_Screenings_for_breast,_cervical_and_colon_cancer_(The_Netherlands)|Survey: National Population Surveys: Screenings for breast, cervical and colon cancer]] === |
|
| |
|
| '''Primary purpose:'''
| | </div> |
|
| |
|
| '''Sponsor, manager or home institution''':
| | == Clinical Practices Guidelines == |
| | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
|
| |
|
| '''Type of information''':
| | === [[hasClinicalGuidelines::Guidelines: IKNL Guidelines Compilation (The Netherlands)|Guidelines: IKNL Guidelines Compilation]] === |
|
| |
|
| '''Source of information''':
| | === [[hasClinicalGuidelines::Guidelines_for_Palliative_Care_(The_Netherlands)|Guidelines: Guidelines for Palliative Care]] === |
|
| |
|
| '''Data level''':
| | === [[hasClinicalGuidelines::Guidelines: NHG Guidelines Compilation (The Netherlands)|Guidelines: NHG Guidelines Compilation]] === |
| | </div> |
|
| |
|
| '''Number of Records:'''
| | == Latest Policymaking Initiatives == |
| | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
|
| |
|
| '''Date range''':
| | === [[hasReport::Reports:_IKNL_(The_Netherlands)|Reports: IKNL]] === |
|
| |
|
| '''Cancer Areas of Interest:'''
| | === [[hasReport::Reports:_Palliaweb_(The_Netherlands)|Reports: Palliaweb]] === |
|
| |
|
| '''Data access''':
| | === [[hasReport::Report:_Breast_cancer_screening_program_(The_Netherlands)|Report: Breast cancer screening program]] === |
|
| |
|
| '''Information/contact for data request''': [ Contact information].
| | === [[hasReport::Report:_EU_Country_Cancer_Profile_2023_(The_Netherlands)|Report: EU Country Cancer Profile 2023]] === |
| -->
| |
|
| |
|
| == [[Databases for Clinical Trials, Surveys and Biobanks]] == | | === [[hasReport::Report:_EU_Country_Cancer_Profile_2025_(The_Netherlands)|Report: EU Country Cancer Profile 2025]] === |
| == [[Electronic Health Records]] == | |
| == [[Clinical Practices Guidelines]] ==
| |
|
| |
|
| == [[Cancer-related Patient Associations and Resources]] == | | === [[hasReport::Report:_The_Dutch_Cancer_Agenda_(The_Netherlands)|Report: The Dutch Cancer Agenda]] === |
|
| |
|
| === Compilation: ESMO Patient Guides === | | === [[hasInitiative::Initiative:_National_Action_Plan_for_Cancer_&_Life_(The_Netherlands)|Initiative: National Action Plan for Cancer & Life]] === |
| | </div> |
|
| |
|
| '''Sponsor, manager or home institution:''' European Society for Medical Oncology
| | == Cancer-related Patient Associations and Resources == |
| | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
|
| |
|
| '''Primary purpose:''' To translate complex medical language into understandable information for patients.
| | === [[hasPatientAssociation::Patient Association: Dutch Breast Cancer Association (Europa Donna Netherlands) (The Netherlands)|Patient Association: Dutch Breast Cancer Association (Europa Donna Netherlands)]] === |
|
| |
|
| '''Available guides:''' Bone Health in Cancer; Cancer Care During the COVID-19 Pandemic; Cancer Pain Management; Immunotherapy Side Effects;
| | === [[hasPatientGuides::Patient Guides: ESMO Patient Guides Compilation (The Netherlands)|Patient Guides: ESMO Patient Guides Compilation]] === |
| Personalised Cancer Medicine; Survivorship; AML; Biliary Tract Cancer; Bladder Cancer; Bone Sarcoma; Breast Cancer; Cervical Cancer; CML; Colorectal Cancer; Endometrial Cancer; Follicular Lymphoma; Glioma; Head and Neck Cancer; Hepatocellular Carcinoma; Multiple Myeloma; Non-Small-Cell Lung Cancer; Oesophageal Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Soft Tissue Sarcoma; Stomach Cancer; Testicular Cancer.
| |
|
| |
|
| '''Type of information:''' Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others.
| | === [[hasPatientResource::Self-help_group:_Dutch_cancer_support_center_“House_by_the_Water”_(The Netherlands)|Self-help group: Dutch cancer support center “House by the Water”]] === |
|
| |
|
| '''Access to information:''' List of guides [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-english [9]].
| | == [[hasQoLandPalliativeCareResearch::Quality_of_Life_and_Palliative_Care_Research_(The_Netherlands)|Quality of Life and Palliative Care Research]] == |
|
| |
|
| == [[Latest Policymaking Initiatives]] == | | __NOTOC__ |
| | <span style="display:none">hasCancerCenter::Netherlands Cancer Institute - Antoni van Leeuwenhoek</span> |
| | <span style="display:none">hasCancerCenter::The Maastricht UMC+ Comprehensive Cancer Center</span> |
| | <span style="display:none">hasCancerCenter::University Medical Center Groningen Comprehensive Cancer Center</span> |
| | <span style="display:none">hasCancerCenter::Erasmus MC Kanker Instituut</span> |
| | <span style="display:none">hasCancerCenter::Radboudumc Centre for Oncology</span> |
| | <span style="display:none">hasCancerCenter::Rijnstate</span> |
| | <span style="display:none">hasHealthcareSystem::Healthcare_System_(The_Netherlands)|Healthcare System</span> |
| | <span style="display:none">hasDatabase::Database:_National_Basic_Register_of_Hospital_Care_(LBZ)_(The_Netherlands)|Database: National Basic Register of Hospital Care (LBZ)</span> |
| | <span style="display:none">hasDatabase::Database:_Netherlands_Cancer_Registry_(NKR)_(The_Netherlands)|Database: Netherlands Cancer Registry (NKR)</span> |
| | <span style="display:none">hasDatabase::Database:_Mortality_by_Cause_of_Death_(The_Netherlands)|Database: Mortality by Cause of Death</span> |
| | <span style="display:none">hasDatabase::Database:_Registry_of_Histo_and_Cytopathology_(The_Netherlands)|Database: Registry of Histo and Cytopathology</span> |
| | <span style="display:none">hasDatabase::Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)|Database: Dutch Institute for Clinical Auditing Databases (DICA)</span> |
| | <span style="display:none">hasDatabase::Survey:_National_Population_Surveys:_Screenings_for_breast,_cervical_and_colon_cancer_(The_Netherlands)|Survey: National Population Surveys: Screenings for breast, cervical and colon cancer</span> |
| | <span style="display:none">hasClinicalGuidelines::Compilation:_IKNL_Guidelines_(The_Netherlands)|Compilation: IKNL Guidelines</span> |
| | <span style="display:none">hasClinicalGuidelines::Guidelines_for_Palliative_Care_(The_Netherlands)|Guidelines for Palliative Care</span> |
| | <span style="display:none">hasClinicalGuidelines::Compilation:_NHG_Guidelines_(The_Netherlands)|Compilation: NHG Guidelines</span> |
| | <span style="display:none">hasReport::Reports:_IKNL_(The_Netherlands)|Reports: IKNL</span> |
| | <span style="display:none">hasReport::Reports:_Palliaweb_(The_Netherlands)|Reports: Palliaweb</span> |
| | <span style="display:none">hasReport::Report:_Breast_cancer_screening_program_(The_Netherlands)|Report: Breast cancer screening program</span> |
| | <span style="display:none">hasReport::Report:_EU_Country_Cancer_Profile_2023_(The_Netherlands)|Report: EU Country Cancer Profile 2023</span> |
| | <span style="display:none">hasReport::Report:_The_Dutch_Cancer_Agenda_(The_Netherlands)|Report: The Dutch Cancer Agenda</span> |
| | <span style="display:none">hasInitiative::Initiative:_National_Action_Plan_for_Cancer_&_Life_(The_Netherlands)|Initiative: National Action Plan for Cancer & Life</span> |
| | <span style="display:none">hasPatientGuides::Compilation:_ESMO_Patient_Guides_(The_Netherlands)|Compilation: ESMO Patient Guides</span> |
| | <span style="display:none">hasQoLandPalliativeCareResearch::Quality_of_Life_and_Palliative_Care_Research_(The_Netherlands)|Quality of Life and Palliative Care Research</span> |
| | <span style="display:none">hasClinicalGuidelines::Compilation:_IKNL_Guidelines_(The_Netherlands)|Guidelines: IKNL Guidelines Compilation</span> |
| | <span style="display:none">hasClinicalGuidelines::Guidelines_for_Palliative_Care_(The_Netherlands)|Guidelines: Guidelines for Palliative Care</span> |
| | <span style="display:none">hasClinicalGuidelines::Compilation:_NHG_Guidelines_(The_Netherlands)|Guidelines: NHG Guidelines Compilation</span> |
| | <span style="display:none">hasClinicalGuidelines::Guidelines: IKNL Guidelines Compilation (The Netherlands)|Guidelines: IKNL Guidelines Compilation</span> |
| | <span style="display:none">hasClinicalGuidelines::Guidelines: NHG Guidelines Compilation (The Netherlands)|Guidelines: NHG Guidelines Compilation</span> |
| | <span style="display:none">hasPatientGuides::Patient Guides: ESMO Patient Guides Compilation (The Netherlands)|Patient Guides: ESMO Patient Guides Compilation</span> |
| | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| | <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> |
| | <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> |
| | <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> |
| | <span style="display:none">hasCancerType::C40-C41: Bone cancers</span> |
| | <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> |
| | <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> |
| | <span style="display:none">hasCancerType::C50: Breast cancer</span> |
| | <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> |
| | <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> |
| | <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> |
| | <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> |
| | <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> |
| | <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> |
| | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> |
| | <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> |
| | <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> |
| | <span style="display:none">hasCancerType::D10-D36: Benign tumour</span> |
| | <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> |
| | <span style="display:none">hasCancerType::unknown</span> |
